Plexus: Buy Rating Affirmed Amid Temporary Revenue Adjustments and Promising Growth Prospects
Earnings Preview: Plexus to Report Financial Results Post-market on October 23
$Plexus(PLXS.US)$ is scheduled to release its financial results post-market on October 23 ET. Earnings PreviewAnalysts estimate $Plexus(PLXS.US)$ to post revenue of USD1.01B for 2024Q4, down 1.58%
New HarperDB Release Delivers a 50% Increase in Replicated Write Performance and Introduces Sharding
Plexus Worldwide Marks Sixth Consecutive Year Supporting Hunger Action Month
At US$137, Is Plexus Corp. (NASDAQ:PLXS) Worth Looking At Closely?
Plexus Sets Fiscal Fourth Quarter and Fiscal Year 2024 Earnings Release Date
Kim Drabik, VP of Corporate Affairs at Plexus Worldwide, Appointed to Direct Selling Association Board of Directors and Named Chairman of the Member Services Committee
Plexus Is Maintained at Buy by Benchmark
Plexus Analyst Ratings
Benchmark Co. Maintains Plexus(PLXS.US) With Buy Rating, Maintains Target Price $150
Benchmark Co. Maintains Plexus(PLXS.US) With Buy Rating, Raises Target Price to $150
Strong Buy for Plexus Amidst Volatility: New Programs and Strategic Positioning Fuel Positive Outlook
Express News | Plexus Corp : Benchmark Raises Target Price to $150
Possible Bearish Signals With Plexus Insiders Disposing Stock
When Should You Buy Plexus Corp. (NASDAQ:PLXS)?
Plexus Holdings Announces Major Shareholding Change
More Than 50 Volunteers From Plexus Worldwide Contribute 10,000 Meals to the Kansas City Region
Plexus (NASDAQ:PLXS) Shareholders Have Earned a 13% CAGR Over the Last Five Years
Plexus Worldwide Announces Andrea McAlister as Chief of Staff to Enhance Executive Operations
Choroid Plexus Disorder Treatment Market Is Expected to Reach US$ 262.3 Million by 2034 | Fact.MR Report